Four weeks of sofosbuvir, ledipasvir and ribavirin with or without interferon give high cure rates in drug users with hepatitis C:a randomized controlled trial (4WIDUC)

Authors
Publication date
1 January 2016
Publisher
'Wiley'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      VBN

      redirect
      oaioai:pure.atira.dk:publications...
      Last time updated on 15/02/2017